Erika Resetkova

Summary

Affiliation: The University of Texas
Country: USA

Publications

  1. ncbi A pictorial journey through variants of ductal carcinoma in situ (DCIS) and DCIS mimickers
    Erika Resetkova
    The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Clin Breast Cancer 12:347-63. 2012
  2. ncbi Pathologic aspects of inflammatory breast carcinoma: part 1. Histomorphology and differential diagnosis
    Erika Resetkova
    Department of Pathology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Semin Oncol 35:25-32. 2008
  3. ncbi Collagenous spherulosis of breast: morphologic study of 59 cases and review of the literature
    Erika Resetkova
    Department of Pathology, University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Am J Surg Pathol 30:20-7. 2006
  4. ncbi Pathologic quiz case: a large, ill-defined cystic breast mass. Invasive cystic hypersecretory duct carcinoma
    Erika Resetkova
    Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA
    Arch Pathol Lab Med 129:e79-80. 2005
  5. ncbi Clinical and radiologic data and core needle biopsy findings should dictate management of cellular fibroepithelial tumors of the breast
    Erika Resetkova
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Breast J 16:573-80. 2010
  6. ncbi Management of radial sclerosing lesions of the breast diagnosed using percutaneous vacuum-assisted core needle biopsy: recommendations for excision based on seven years' of experience at a single institution
    Erika Resetkova
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Breast Cancer Res Treat 127:335-43. 2011
  7. ncbi Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome
    Kim L Wang
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Cancer 109:658-67. 2007
  8. ncbi Loss of annexin A1 expression in breast cancer progression
    Ying Cao
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Appl Immunohistochem Mol Morphol 16:530-4. 2008
  9. ncbi Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment
    Erika Resetkova
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 46202, USA
    Breast Cancer Res Treat 123:97-108. 2010
  10. ncbi Invasive paget disease of the breast: clinicopathologic study of an underrecognized entity in the breast
    Xiuzhen Duan
    Department of Pathology, The University of Texas Health Science Center Department of Pathology, Houston, TX 77030, USA
    Am J Surg Pathol 36:1353-8. 2012

Collaborators

Detail Information

Publications35

  1. ncbi A pictorial journey through variants of ductal carcinoma in situ (DCIS) and DCIS mimickers
    Erika Resetkova
    The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Clin Breast Cancer 12:347-63. 2012
    ..The currently controversial entities are also discussed...
  2. ncbi Pathologic aspects of inflammatory breast carcinoma: part 1. Histomorphology and differential diagnosis
    Erika Resetkova
    Department of Pathology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Semin Oncol 35:25-32. 2008
    ..The focus of this chapter is on the histomorphologic characteristics of IBC and its broad differential diagnosis...
  3. ncbi Collagenous spherulosis of breast: morphologic study of 59 cases and review of the literature
    Erika Resetkova
    Department of Pathology, University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Am J Surg Pathol 30:20-7. 2006
    ..Caution is needed not to overinterpret collagenous spherulosis as atypical or ductal carcinoma in situ, especially on core needle biopsy specimens...
  4. ncbi Pathologic quiz case: a large, ill-defined cystic breast mass. Invasive cystic hypersecretory duct carcinoma
    Erika Resetkova
    Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA
    Arch Pathol Lab Med 129:e79-80. 2005
  5. ncbi Clinical and radiologic data and core needle biopsy findings should dictate management of cellular fibroepithelial tumors of the breast
    Erika Resetkova
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Breast J 16:573-80. 2010
    ..Follow-up alone may be an appropriate alternative for a subset of patients, given a good clinical, pathologic, and radiologic correlation...
  6. ncbi Management of radial sclerosing lesions of the breast diagnosed using percutaneous vacuum-assisted core needle biopsy: recommendations for excision based on seven years' of experience at a single institution
    Erika Resetkova
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Breast Cancer Res Treat 127:335-43. 2011
    ..We describe the clinical management of RSL diagnosed using a percutaneous vacuum-assisted 9- or 11-gauge stereotactically guided core needle biopsy (SCNB) device...
  7. ncbi Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome
    Kim L Wang
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Cancer 109:658-67. 2007
    ..It is not known whether EGFR plays a similar role in esophageal and EGJ adenocarcinomas...
  8. ncbi Loss of annexin A1 expression in breast cancer progression
    Ying Cao
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Appl Immunohistochem Mol Morphol 16:530-4. 2008
    ..Therefore, to accurately characterize the ANXA1 expression pattern, we used microarray analysis and matched patient samples to evaluate progressive alterations in ANXA1 protein expression during malignant transformation and metastasis...
  9. ncbi Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment
    Erika Resetkova
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 46202, USA
    Breast Cancer Res Treat 123:97-108. 2010
    ..The novel finding is that tumor microenvironment may play a significant role in determining the prognostic impact of stem/progenitor cells in human breast tumors...
  10. ncbi Invasive paget disease of the breast: clinicopathologic study of an underrecognized entity in the breast
    Xiuzhen Duan
    Department of Pathology, The University of Texas Health Science Center Department of Pathology, Houston, TX 77030, USA
    Am J Surg Pathol 36:1353-8. 2012
    ..Further studies are required to determine whether invasion in MPD has clinical significance...
  11. ncbi Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary data
    Selin Carkaci
    Department of Diagnostic Radiology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4009, USA
    J Nucl Med 50:231-8. 2009
    ..Our objective was to retrospectively evaluate 18F-FDG PET/CT in the initial staging of inflammatory breast cancer (IBC)...
  12. ncbi Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings
    Wei T Yang
    The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1350, Houston, TX, 77030, USA
    Breast Cancer Res Treat 109:417-26. 2008
    ..To describe the role of Positron Emission Tomography/Computed Tomography (PET/CT), Magnetic Resonance Imaging (MRI), sonography, and mammography in patients with inflammatory breast cancer (IBC)...
  13. ncbi Pathological examination of sentinel lymph node in breast cancer: potential problems and possible solutions
    Syed A Hoda
    Department of Pathology, Weill Medical College of Cornell University and New York Presbyterian Hospital Weill Cornell Medical Center, New York, New York 10021, USA
    Microsc Res Tech 59:85-91. 2002
    ....
  14. ncbi Benign heterotopic epithelial inclusions in axillary lymph nodes. Histological and immunohistochemical patterns
    Erika Resetkova
    Department of Pathology, New York Presbyterian-Weill Cornell Center, New York, NY 10021, USA
    Arch Pathol Lab Med 127:e25-7. 2003
    ..We describe 2 histologically different examples of benign epithelial inclusions in nonsentinel axillary lymph nodes, each with an unusual clinical presentation...
  15. ncbi Assessment of two automated imaging systems in evaluating estrogen receptor status in breast carcinoma
    Sumita Gokhale
    Department of Pathology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Appl Immunohistochem Mol Morphol 15:451-5. 2007
    ..In 4 of these, the percentage of cells staining for ER was low (0% to 20%). Overall, the 2 systems were comparable, and discrepant results were most frequently seen when analyzing tumors with low levels of ER positive cells...
  16. ncbi Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ
    Lei Huo
    Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 107:1760-8. 2006
    ..The authors recommended the inclusion of these predictors in the guidelines for selecting patients for SLN biopsy to reduce the number of unnecessary procedures...
  17. ncbi Preoperative diagnosis of clear cell "sugar" tumor of the lung by computed tomography-guided fine-needle biopsy and core-needle biopsy
    Marcia Edelweiss
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Ann Diagn Pathol 11:421-6. 2007
    ..We underscore the importance of cytologic and histologic correlation and the role of ancillary studies in differentiating this lesion from other primary or metastatic clear cell tumors of the lung...
  18. ncbi Gross cystic disease fluid protein-15 and mammaglobin A expression determined by immunohistochemistry is of limited utility in triple-negative breast cancer
    Lei Huo
    Department of Pathology, The University of Texas MD Anderson Cancer Centre, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Histopathology 62:267-74. 2013
    ..Data on their expression in triple-negative breast cancer (TNBC) are very limited. The aim of this study was to examine the expression of these markers in TNBC to determine their utility in pathological diagnosis...
  19. ncbi Imaging features of micropapillary DCIS: correlation with clinical and histopathological findings
    Yien Sien Lee
    Department of Diagnostic Radiology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
    Acad Radiol 18:797-803. 2011
    ..The aim of this study was to describe the mammographic, sonographic, and magnetic resonance imaging (MRI) findings of micropapillary ductal carcinoma in situ...
  20. ncbi Primary osteosarcoma of the breast: report of 2 cases
    Armita Bahrami
    Department of Pathology, Baylor College of Medicine, Houston, TX, USA
    Arch Pathol Lab Med 131:792-5. 2007
    ....
  21. ncbi A large, fungating breast mass. Secretory carcinoma with apocrine differentiation
    Paula Anderson
    Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
    Arch Pathol Lab Med 130:e50-2. 2006
  22. ncbi Giant cell tumor of soft tissue arising in breast
    Steve A May
    Department of Pathology, Unit 085, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA
    Ann Diagn Pathol 11:345-9. 2007
    ..To our knowledge, this is the first case report of a GCT-ST arising in the breast associated with a fatal outcome. The distinction of this entity from other more common primary breast tumors with giant cell morphology is also emphasized...
  23. ncbi "Ossifying-type" mammary calcifications
    Erika Resetkova
    Department of Pathology, New York Presbyterian Hospital-Weill Medical College of Cornell University, NY 10021, USA
    Arch Pathol Lab Med 126:995-6. 2002
  24. ncbi Expression of high-molecular-weight cytokeratin (34betaE12) is an independent predictor of disease-free survival in patients with triple-negative tumours of the breast
    Rutika Mehta
    Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana, USA
    J Clin Pathol 63:744-7. 2010
    ..Expression of 34betaE12 predicts disease-free and overall survival in patients with triple-negative tumours. Additional studies are planned to confirm these initial findings...
  25. ncbi Breast carcinoma with choriocarcinomatous features
    Erika Resetkova
    Department of Pathology, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
    Ann Diagn Pathol 8:74-9. 2004
    ..Immunostaining for the beta subunit of human chorionic gonadotropin was localized mostly, but not entirely, to multinucleated syncytiotrophoblast-like giant cells within both tumors...
  26. ncbi Prognostic value of P53, MDM-2, and MUC-1 for patients with inflammatory breast carcinoma
    Erika Resetkova
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston 77030, USA
    Cancer 101:913-7. 2004
    ..CONCLUSIONS: Expression of P53 and MUC-1 may be predictive of treatment efficacy and outcome for patients with IBC. Furthermore, these two markers may represent novel therapeutic targets in such patients...
  27. ncbi Trastuzumab administration associated with change in HER2 status
    Shaheenah Dawood
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Clin Breast Cancer 8:366-9. 2008
    ..We present the unusual case of a patient with HER2/neu-positive stage I breast cancer who, after receiving adjuvant trastuzumab, relapsed to develop HER2/neu-negative metastatic disease...
  28. ncbi Primary gastrointestinal stromal tumor of the esophagus in an HIV-positive patient
    Anthony Padula
    Department of Hematophatology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Ann Diagn Pathol 9:49-53. 2005
    ..The occurrence of this tumor in an HIV-positive patient is coincidental, and it resulted in an extremely unusual metastatic site that has not been reported for GISTs...
  29. ncbi Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome
    Kim L Wang
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, 77030, USA
    Clin Cancer Res 12:4598-604. 2006
    ..However, the role of ANXA1 in esophageal adenocarcinoma is unclear. Our goal was to evaluate ANXA1 expression and determine its prognostic significance in adenocarcinoma of the esophagus and esophagogastric junction...
  30. ncbi Cytologic features of renal medullary carcinoma
    Lina Assad
    Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 105:28-34. 2005
    ..The clinical findings are key to diagnosing renal medullary carcinoma...
  31. ncbi Ten-year follow-up of mammary carcinoma arising in microglandular adenosis treated with breast conservation
    Erika Resetkova
    Department of Pathology, New York Presbyterian Hospital Weill Cornell Center, New York, NY 10021, USA
    Arch Pathol Lab Med 127:77-80. 2003
    ..We report here the unique 10-year follow-up of a woman who underwent breast conservation treatment for carcinoma that arose in microglandular adenosis...
  32. ncbi Interpretative problems and preparative technique influence reliability of intraoperative parathyroid touch imprints
    Davis X Yao
    Department of Pathology, New York Presbyterian Hospital-Weill Cornell Center, and Weill Medical College of Cornell University, New York, NY 10021, USA
    Arch Pathol Lab Med 127:64-7. 2003
    ..Awareness of interpretative problems and attention to preparation of TIPs may further enhance the accuracy of TIP during intraoperative consultation...
  33. ncbi Megakaryocytes mimicking metastatic breast carcinoma
    Syed A Hoda
    Department of Pathology, Weill Medical College of Cornell University and New York Presbyterian Hospital Weill Cornell Medical Center, New York, NY 10021, USA
    Arch Pathol Lab Med 126:618-20. 2002
    ..Megakaryocytes should be added to the list of benign histologic abnormalities that may simulate metastatic carcinoma in a sentinel lymph node...
  34. ncbi Pseudoangiomatous stromal hyperplasia tumor: a clinical, radiologic and pathologic study of 26 cases
    Marco Ferreira
    Servico de Anatomia Patologica, Instituto Português de Oncologia de Lisboa Francisco Gentil, EPE, Lisboa, Portugal
    Mod Pathol 21:201-7. 2008
    ....
  35. ncbi Images in pathology. Mammary crystalloids
    Erika Resetkova
    Department of Pathology New York Presbyterian Hospital-Weill, Medical College of Cornell University, New York, USA
    Int J Surg Pathol 10:148. 2002